ENCell Co (XKRX:456070) EPS (Basic) : ₩-1,385.00 (TTM As of Mar. 2025)

View and export this data going back to 2024. Start your Free Trial

What is ENCell Co EPS (Basic)?

ENCell Co's basic earnings per share (Basic EPS) for the three months ended in Mar. 2025 was ₩-431.00. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Mar. 2025 was ₩-1,385.00.

ENCell Co's EPS (Diluted) for the three months ended in Mar. 2025 was ₩-431.00. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2025 was ₩-1,385.00.

ENCell Co's EPS without NRI for the three months ended in Mar. 2025 was ₩-430.87. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2025 was -1,391.38.

During the past 3 years, the average EPS without NRI Growth Rate was 57.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 5 years, ENCell Co's highest 3-Year average EPS without NRI Growth Rate was 57.20% per year. The lowest was 48.10% per year. And the median was 52.65% per year.

ENCell Co EPS (Basic) Historical Data

The historical data trend for ENCell Co's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ENCell Co EPS (Basic) Chart

ENCell Co Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Dec24

EPS (Basic)

-36,336.00

-35,004.00

-9,548.00

-818.00

-1,729.00

ENCell Co Quarterly Data
	Dec20	Dec21	Dec22	Mar23	Sep23	Dec23	Mar24	Sep24	Dec24	Mar25
EPS (Basic)	Get a 7-Day Free Trial					-74.00	-375.00	-453.00	-501.00	-431.00

ENCell Co EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

ENCell Co's Basic EPS for the fiscal year that ended in Dec. 2024 is calculated as

Basic EPS (A: Dec. 2024 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(-15209.839	-	0)	/	8.794
	=	-1,729.57

ENCell Co's Basic EPS for the quarter that ended in Mar. 2025 is calculated as

Basic EPS (Q: Mar. 2025 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(-4648.035	-	0)	/	10.773
	=	-431.45

EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-1,385.00

ENCell Co (XKRX:456070) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

ENCell Co EPS (Basic) Related Terms

Thank you for viewing the detailed overview of ENCell Co's EPS (Basic) provided by GuruFocus.com. Please click on the following links to see related term pages.

ENCell Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ENCell Co Ltd (XKRX:456070) » Definitions » EPS (Basic)

Comparable Companies

Traded in Other Exchanges

N/A

Address

701 Yeongdong-daero, 11th floor, Gangnam-gu, Seoul, KOR

Website

http://www.encellinc.com

ENCell Co Ltd is a biopharmaceutical company. The company is engaged in conducting biopharmaceutical contract development and manufacturing (CDMO) service business and cell, gene therapy new drug development business for rare/incurable muscle diseases such as Charcot-Marie-Tooth disease, Duchenne muscular dystrophy, and sarcopenia.

ENCell Co Headlines

No Headlines